Carbamazepine
(CBZ) is an anticonvulsant medication with highly
persistent properties in the aquatic environment, where it has the
potential to affect nontarget biota. Because CBZ and many other pharmaceuticals
are not readily removed in conventional sewage treatment plants (STP),
additional STP effluent treatment technologies are being evaluated
and implemented. Whole effluent ozonation is a prospective method
to remove pharmaceuticals such as CBZ, yet knowledge on the toxicity
of CBZ ozonation byproducts (OBPs) is lacking. This study presents,
for the first time, in vivo individual and mixture toxicity of four
putative OBPs, that is, carbamazepine 10,11-epoxide, 10,11-Dihydrocarbamazepine,
1-(2-benzaldehyde)-4-hydro-(1H,3H)-quinazoline-2-one (BQM), and 1-(2-benzaldehyde)-(1H,3H)-quinazoline-2,4-dione (BQD) in developing zebrafish
(Danio rerio) embryos. BQM and BQD
were isolated from the ozonated solution as they were not commercially
available. The study confirmed that the OBP mixture caused embryotoxic
responses comparable to that of ozonated CBZ. Individual compound
embryotoxicity assessment further revealed that BQM and BQD were the
drivers of embryotoxicity. OBP chemical stability in ozonated CBZ
water solution during 2 week dark storage at 22 °C was also assessed.
The OBP concentrations remained over time, except for BQD which decreased
by 94%. Meanwhile, ozonated CBZ persistently induced embryotoxicity
over 2 week storage, potentially illustrating environmental concern.